Condition: Medicated for patients suffering from Pulmonary/Respiratory Diseases. Ease of Use: ★★★★ Cinqair (reslizumab) is an interleukin-5 antagonist monoclonal antibody which is generally recommended for the patients suffering from extreme asthma, It is prescribed to patients who are 18 years old and over with an eosinophilic phenotype. It is not recommended for other problems which are caused […]
